AI-generated summary
This retrospective study at Brest University Hospital reviewed 37 patients (74 eyes) with meibomian gland dysfunction treated with three sessions of a combined intense pulsed light and photo-biomodulation device, two weeks apart. The authors report significant improvements in quality-of-life and ocular surface measures at 1 and 3 months, with good tolerance apart from two cases of herpetic keratitis that resolved.
- Participants
- 37
- Who or what was studied
- 37 patients (74 eyes) with meibomian gland dysfunction at Brest University Hospital, treated between January 2019 and April 2020
- Limits stated in the abstract
- The study is retrospective and uses a single cohort without a control group, so causal conclusions are limited.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Primary outcome, Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.